title: What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
abstract: Early recanalization of the occluded culprit coronary artery clearly reduces infarct size in both animal models and patients and improves clinical outcomes. Unfortunately, reperfusion can seldom be accomplished before some myocardium infarcts. As a result there has been an intensive search for interventions that will make the heart resistant to infarction so that reperfusion could salvage more myocardium. A number of interventions have been identified in animal models, foremost being ischemic preconditioning. It protects by activating signaling pathways that prevent lethal permeability transition pores from forming in the heart's mitochondria at reperfusion. Such conditioning can be accomplished in a clinically relevant manner either by staccato reperfusion (ischemic postconditioning) or by pharmacological activation of the conditioning signaling pathways prior to reperfusion. Unfortunately, clinical trials of ischemic postconditioning and pharmacologic conditioning have been largely disappointing. We suggest that this may be caused by inappropriate use as models intended to mimic the clinical scenario of young healthy animals that receive none of the many drugs currently given to our patients. Patients may be resistant to some forms of conditioning because of comorbidities, for example, diabetes, or they may already be conditioned by adjunct medications, for example, P2Y12 inhibitors or opioids. Incremental technological improvements in patient care may render some approaches to cardioprotection redundant, and thus the clinical target may be continually changing, while our animal models have not kept pace. In remote conditioning, a limb is subjected to ischemia/reperfusion prior to or during coronary reperfusion. Its mechanism is not as well understood as that of ischemic preconditioning, but the results have been very encouraging. In the present article, we will review ischemic, remote, and pharmacologic conditioning and possible confounders that could interfere with their efficacy in clinical trials in 2 settings of myocardial ischemia: (1) primary angioplasty in acute myocardial infarction and (2) elective angioplasty.
authors: Second University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece.
authors: Efstathios K
authors: EK
authors: Iliodromitis
authors: Department of Physiology, University of South Alabama College of Medicine, Mobile, AL, USA Department of Medicine, University of South Alabama College of Medicine, Mobile, AL, USA.
authors: Michael V
authors: MV
authors: Cohen
authors: Second University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece.
authors: Nikolaos
authors: N
authors: Dagres
authors: Department of Pharmaceutical Chemistry, School of Pharmacy, University of Athens, Athens, Greece.
authors: Ioanna
authors: I
authors: Andreadou
authors: Second University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece.
authors: Dimitrios Th
authors: DT
authors: Kremastinos
authors: Second University Department of Cardiology, Medical School, Attikon General Hospital, University of Athens, Athens, Greece jdowney@southalabama.edu.
authors: James M
authors: JM
authors: Downey
mesh_terms: D017130:Angioplasty / Q000379:methods; D000818:Animals; D006328:Cardiac Catheterization / Q000379:methods; D054059:Coronary Occlusion / Q000473:pathology / Q000628:therapy; D006801:Humans; D057775:Ischemic Postconditioning / Q000379:methods*; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods*; D009203:Myocardial Infarction / Q000517:prevention & control / Q000628:therapy; D017202:Myocardial Ischemia / Q000517:prevention & control / Q000628:therapy; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D015398:Signal Transduction
keywords: angioplasty; cardioprotection; myocardial infarction; postconditioning; preconditioning; remote conditioning